Norfloxacin monodose use in patients with cholera in Salta Argentina
Rev. Inst. Med. Trop. Säo Paulo
;
38(3): 217-219, May-Jun. 1996.
Article
in English
| LILACS
| ID: lil-320643
RESUMO
The use of monodose (800 mg) per os of Norfloxacin was evaluated in 32 patients with cholera at Salvador Mazza's Hospital, Salta, Argentina. It was considered the celerity in negativization of stool culture (100 of cases 12 hours post administration), it efficiency along time (24/24 controlled patients were negative at 10th day) and MIC of isolated strains (100 of strains were sensitive range 0.008 to 0.016 micrograms/ml). It was included oral administration of sorbitol 70 in peanut oil in order to study patients at 10th day's control. This method could be an alternative one in the study of asymptomatic carrier. Norfloxacin monodose shows good performance in early negativization of stool culture and it was also effective along the whole observation period, suggesting it could prevent carriage.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Norfloxacin
/
Cholera
/
Anti-Infective Agents
Limits:
Adolescent
/
Adult
/
Aged80
/
Humans
/
Male
Country/Region as subject:
South America
/
Argentina
Language:
English
Journal:
Rev. Inst. Med. Trop. Säo Paulo
Journal subject:
Tropical Medicine
Year:
1996
Type:
Article
Affiliation country:
Argentina
Institution/Affiliation country:
Hospital de Infecciosas F. J. Muñiz/AR
/
Hospital de Salvador Mazza/AR
Similar
MEDLINE
...
LILACS
LIS